| 1. |
Kuckuck, F. W., Edwards, B. S., and Sklar, L. A. (2001) High throughput flow cytometry. Cytometry 44, 83–90.
|
| |
| 2. |
Ramirez, S., Aiken, C. T., Andrzejewski, B., Sklar, L. A., and Edwards, B. S. (2003) High-throughput flow cytometry: validation
in microvolume bioassays. Cytometry A 53, 55–65.
|
| |
| 3. |
Young, S. M., Bologa, C., Prossnitz, E., Oprea, T. I., Sklar, L. A., and Edwards, B. S. (2005) High-throughput screening with
HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands. J. Biomol. Screen. 10, 374–382.
|
| |
| 4. |
Edwards, B. S., Bologa, C., Young, S. M., Balakin, K. V., Prossnitz, E., Savchuck, N. P., Sklar, L. A., and Oprea, T. I. (2005)
Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor
antagonists. Mol. Pharmacol. 68, 1301–1310.
|
| |
| 5. |
Edwards, B. S., Young, S. M., Oprea, T. I., Bologa, C., Prossnitz, E., and Sklar, L. A. (2006) Biomolecular screening of formylpeptide
receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform. Nat. Protocols 1, 59–66.
|
| |
| 6. |
Migeotte, I., Communi, D., and Parmentier, M. (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled
receptors controlling immune responses. Cytokine Growth Factor Rev. 17, 501–519.
|
| |
| 7. |
Le, Y., Murphy, P. M., and Wang, J. M. (2002) Formyl-peptide receptors revisited. Trends Immunol. 23, 541–548.
|
| |
| 8. |
Oppenheim, J. J., Zachariae, C. O., Mukaida, N., and Matsushima, K. (1991) Properties of the novel proinflammatory supergene
“intercrine” cytokine family. Annu. Rev. Immunol. 9, 617–648.
|
| |
| 9. |
Murphy, P. M. (1996), in Chemoattractant Ligands and Their Receptors (Horuk, R., ed.), CRC Press, Boca Raton, FL, pp. 269–299.
|
| |
| 10. |
Prossnitz, E. R., and Ye, R. D. (1997) The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74, 73–102.
|
| |
| 11. |
Ye, R. D., Cavanagh, S. L., Quehenberger, O., Prossnitz, E. R., and Cochrane, C. G. (1992) Isolation of a cDNA that encodes
a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184, 582–589.
|
| |
| 12. |
Snipe, J. D. (1990), in Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation (Oppenheim, J. J. and
Shevac, E. M., eds.), Oxford University Press, New York, pp. 259–273.
|
| |
| 13. |
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer,
B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands
derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448–6453.
|
| |
| 14. |
Kalaria, R. N. (1999) Microglia and Alzheimer’s disease. Curr. Opin. Hematol. 6, 15–24.
|
| |
| 15. |
Brown, D. R., Schmidt, B., and Kretzschmar, H. A. (1996) Role of microglia and host prion protein in neurotoxicity of a prion
protein fragment. Nature 380, 345–347.
|
| |
| 16. |
Le, Y., Yazawa, H., Gong, W., Yu, Z., Ferrans, V. J., Murphy, P. M., and Wang, J. M. (2001) The neurotoxic prion peptide fragment
PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol. 166,
1448–1451.
|
| |
| 17. |
Bae, Y. S., Song, J. Y., Kim, Y., He, R., Ye, R. D., Kwak, J. Y., Suh, P. G., and Ryu, S. H. (2003) Differential activation
of formyl peptide receptor signaling by peptide ligands. Mol. Pharmacol. 64, 841–847.
|
| |
| 18. |
Bae, Y. S., Yi, H. J., Lee, H. Y., Jo, E. J., Kim, J. I., Lee, T. G., Ye, R. D., Kwak, J. Y., and Ryu, S. H. (2003) Differential
activation of formyl peptide receptor-like 1 by peptide ligands. J. Immunol. 171, 6807–6813.
|
| |
| 19. |
Zhang, J. H., Chung, T. D., and Oldenburg, K. R. (1999) A simple statistical parameter for use in evaluation and validation
of high throughput screening assays. J. Biomol. Screen. 4, 67–73.
|
| |